Surface modification of liposomes by saccharides: vesicle size and stability of lactosyl liposomes studied by photon correlation spectroscopy.

The cell glycocalyx is an attractive model for surface modification of liposomes, because its hydrated oligosaccharide layer inhibits nonspecific protein adsorption and can provide specificity towards desired sites. Here, we report on the use of lactose as a model saccharide to modify the liposome surface and examine the vesicle size and stability. Two kinds of lactosyl lipids, including lactosyl ether-lipid (6a) and lactosyl ester-lipid (6b), which contain octadecyl and octadecanoyl as the lipid tails, respectively, were synthesized and their liposomes were prepared by the extrusion method. The effects of glycolipid structure, concentration, and the pore size of the extrusion membrane on vesicle size and stability were investigated at room temperature by photon correlation spectroscopy (PCS). All liposomes with 5 or 10 mol% of lactosyl lipids had a narrow size distribution and remained stable at room temperature for at least one month, which is comparable to 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC)- and poly(ethylene glycol) (PEG)-liposomes. The maximum incorporation of lactosyl ester-lipid into liposomes was 15 mol%, compared with only 10 mol% for the lactosyl ether-lipid. The lactosyl ester-liposomes had better stability and exhibited less size change than the lactosyl ether-liposomes at 15 or 20 mol% of lactosyl lipids incorporated. This may be attributed to the better structural compatibility of lactosyl ester-lipid with DSPC. The PCS results show that the glycolipid structure and concentrations are major factors that affect vesicle stability, while the pore size of extrusion membranes has no influence.

[1]  H. Gabius,et al.  Studies on carbohydrate-binding proteins using liposome-based systems--I. Preparation of neoglycoprotein-conjugated liposomes and the feasibility of their use as drug-targeting devices. , 1992, The International journal of biochemistry.

[2]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[3]  D. Thompson,et al.  Size and structure of spontaneously forming liposomes in lipid/PEG-lipid mixtures. , 2002, Biophysical journal.

[4]  M. Shive,et al.  Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[5]  D. Needham,et al.  Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). , 1995, Biophysical journal.

[6]  J. Kreuter,et al.  Colloidal Drug Delivery Systems , 1994 .

[7]  N V Bovin,et al.  Endogenous lectins as targets for drug delivery. , 2000, Advanced drug delivery reviews.

[8]  N. Van Rooijen,et al.  Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. , 1994, Biochimica et biophysica acta.

[9]  S. Wen,et al.  Unprotected oligosaccharides as phase tags: solution-phase synthesis of glycopeptides with solid-phase workups. , 2001 .

[10]  N. Mullah,et al.  New chemoenzymatic approach to glyco-lipopolymers: practical preparation of functionally active galactose–poly(ethylene glycol)–distearoylphosphatidic acid (Gal–PEG–DSPA) conjugate , 1999 .

[11]  R. Marchant,et al.  Conformations of Short-Chain Poly(ethylene oxide) Lipopolymers at the Air−Water Interface: A Combined Film Balance and Surface Tension Study , 2001 .

[12]  F. Arnold,et al.  A Metal-Chelating Lipid for 2D Protein Crystallization via Coordination of Surface Histidines , 1997 .

[13]  K. Maruyama,et al.  Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. , 1999, International journal of pharmaceutics.

[14]  F. Szoka,et al.  Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. , 1979, Biochimica et biophysica acta.

[15]  J. Israelachvili.  Intermolecular and surface forces , 1985 .

[16]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[17]  D. Marsh,et al.  Phospholipid Bilayers: Physical Principles and Models , 1987 .

[18]  G Blume,et al.  Molecular mechanism of the lipid vesicle longevity in vivo. , 1993, Biochimica et biophysica acta.

[19]  B. Ninham,et al.  Theory of self-assembly of hydrocarbon amphiphiles into micelles and bilayers , 1976 .

[20]  R. Ho,et al.  Trends and developments in liposome drug delivery systems. , 2001, Journal of pharmaceutical sciences.

[21]  Luke S. S. Guo,et al.  Sialyl Lewis x Liposomes as a Multivalent Ligand and Inhibitor of E-Selectin Mediated Cellular Adhesion , 1996 .

[22]  A. Janoff.  Liposomes: Rational Design , 1998 .

[23]  V. Torchilin,et al.  Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. , 1994, Biochimica et biophysica acta.

[24]  T. Allen,et al.  Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. , 1989, Biochimica et biophysica acta.

[25]  Y. Kawashima,et al.  Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[26]  N. Das,et al.  Sugar‐coated liposomes: a novel delivery system for increased drug efficacy and reduced drug toxicity , 1993, Biotechnology and applied biochemistry.

[27]  M. Woodle,et al.  Controlling liposome blood clearance by surface-grafted polymers. , 1998, Advanced drug delivery reviews.

[28]  L. Huang,et al.  Effect of chemically modified GM1 and neoglycolipid analogs of GM1 on liposome circulation time: evidence supporting the dysopsonin hypothesis. , 1993, Biochimica et biophysica acta.

[29]  M. Ueno,et al.  Physicochemical properties of PEG-grafted liposomes. , 2002, Chemical & pharmaceutical bulletin.

[30]  Severian Dumitriu,et al.  Polysaccharides : structural diversity and functional versatility , 1998 .

[31]  Uchiyama,et al.  The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. , 1999, Advanced drug delivery reviews.

[32]  M. Woodle,et al.  Sterically stabilized liposome therapeutics , 1995 .

[33]  S. Dumitriu.  Polysaccharides : Structural Diversity and Functional Versatility, Second Edition , 2004 .

[34]  M. Bally,et al.  Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential. , 1985, Biochimica et biophysica acta.

[35]  Dexi Liu.  Biological factors involved in blood clearance of liposomes by liver , 1997 .

[36]  R. Marchant,et al.  Synthesis and characterization of oligomaltose-grafted lipids with application to liposomes. , 2002, Journal of colloid and interface science.

[37]  D. Letourneur,et al.  Liposomes coated with chemically modified dextran interact with human endothelial cells. , 1999, Journal of biomedical materials research.

[38]  E. Chiellini,et al.  Polymers in Medicine: Biomedical and Pharmacological Applications , 1983 .

[39]  M. Haga,et al.  Effect of surface modification of liposomes with sialoglycopeptide on their clearance from the circulation. , 1986, Chemical & pharmaceutical bulletin.

[40]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[41]  Thisbe K. Lindhorst,et al.  Essentials of carbohydrate chemistry and biochemistry , 2000 .